LCM
TEVA icon

Laurion Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Laurion Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-116,600
Closed -$1.05M – 962
2020
Q3 		$1.05M Buy
+116,600
New +$1.23M 0.01% 416
2019
Q4 		– Sell
-269,100
Closed -$2.4M – 1221
2019
Q3 		$1.85M Buy
269,100
+162,300
+152% +$1.24M 0.01% 511
2019
Q2 		$986K Buy
+106,800
New +$1.29M 0.01% 573
2019
Q1 		– Sell
-12,818
Closed -$198K – 1276
2018
Q4 		$198K Buy
12,818
+10,700
+505% +$219K ﹤0.01% 970
2018
Q3 		$46K Sell
2,118
-5,050
-70% -$117K ﹤0.01% 1119
2018
Q2 		$174K Sell
7,168
-8,050
-53% -$164K ﹤0.01% 1216
2018
Q1 		$260K Sell
15,218
-167,000
-92% -$3.26M ﹤0.01% 1169
2017
Q4 		$3.45M Buy
182,218
+19,129
+12% +$288K 0.02% 629
2017
Q3 		$2.87M Buy
+163,089
New +$3.67M 0.01% 661
2017
Q2 		– Sell
-107,579
Closed -$3.33M – 1859
2017
Q1 		$3.45M Buy
107,579
+48,474
+82% +$1.65M 0.03% 501
2016
Q4 		$2.14M Sell
59,105
-828,164
-93% -$33.1M 0.02% 556
2016
Q3 		$40.8M Buy
887,269
+460,559
+108% +$24M 0.38% 56
2016
Q2 		$21.4M Sell
426,710
-40,883
-9% -$2.18M 0.34% 74
2016
Q1 		$25M Buy
467,593
+160,952
+52% +$9.44M 0.39% 65
2015
Q4 		$20.1M Buy
306,641
+262,941
+602% +$16.2M 0.19% 108
2015
Q3 		$2.47M Buy
+43,700
New +$2.83M 0.03% 309

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Laurion Capital Management's TEVA Position: Q4 2020 in Review

Laurion Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2020, closing a stake of 116,600 shares — an estimated $1.05M sold.

Laurion Capital Management first reported a position in TEVA in Q3 2015 and held it in 16 quarters. The position peaked at $40.8M in Q3 2016. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Laurion Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2020 after selling out during the quarter.
  • Laurion Capital Management sold 116,600 Teva Pharmaceutical Industries Limited shares in Q4 2020, an estimated $1.05M.
  • Laurion Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2015 and held it in 16 quarters.
  • Laurion Capital Management's Teva Pharmaceutical Industries Limited position peaked at $40.8M in Q3 2016.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2020.

Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.